PDS Biotechnology Corporation (PDSB) Stock Price

0.6671 ▼ -0.0249 (-3.60%)
Open: 0.6929 Vol: 407.72K Day's range: 0.6298 - 0.6929 Mar 03, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PDSB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.67▲ 0.67▼ 0.67▼ 0.69▼ 0.68▼
MA10 0.67▲ 0.67▼ 0.67▼ 0.67▼ 0.80▼
MA20 0.67▼ 0.67▼ 0.67▼ 0.69▼ 0.84▼
MA50 0.67▼ 0.68▼ 0.67▲ 0.82▼ 1.08▼
MA100 0.68▼ 0.67▲ 0.68▼ 0.86▼ 1.86▼
MA200 0.67▲ 0.69▼ 0.77▼ 1.07▼ 3.84▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ 0.000▲ -0.001▼ 0.007▲ -0.007▼
RSI 49.203▼ 48.012▼ 48.385▼ 38.832▼ 36.233▼
STOCH 45.357     71.076     61.027     59.370     11.803▼
WILL %R -19.410▲ -31.524     -31.524     -55.563     -87.992▼
CCI 24.479     -80.802     -64.838     -64.743     -108.790▼
Latest Filters Detected On PDSB
MA $PDSB Price Crossed Below MA(13) Set Alert
MA $PDSB Price Crossed Below MA(7) Set Alert
CDL $PDSB Dark Cloud Cover Candlestick Pattern Detected Set Alert
PDS Biotechnology Corporation News
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Monday, March 02, 2026 09:34 AM
It’s been a few years since we last spoke. Can you give our readers a refresher on the company and its history? Dr. Bedu-Addo: So, PDS Biotechnology is developing immunotherapies that train the immune ...
PDS Biotechnology Corporation: PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary ...
Friday, February 20, 2026 04:36 AM
PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune ...
PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101
Thursday, January 22, 2026 12:46 AM
PRINCETON, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
PDSB historical stock data
date open high low close volume
03/03/26 0.6929 0.6929 0.6298 0.6671 407,723
02/03/26 0.6491 0.692 0.6435 0.692 207,711
27/02/26 0.69 0.712 0.6609 0.675 275,932
26/02/26 0.7018 0.715 0.6801 0.6993 200,789
25/02/26 0.6528 0.7256 0.6506 0.709 365,457
24/02/26 0.64 0.665 0.633 0.6592 291,062
23/02/26 0.65 0.65 0.6012 0.6401 0
20/02/26 0.705 0.7305 0.64 0.648 1,212,272
19/02/26 0.6728 0.6897 0.65 0.6578 540,929
18/02/26 0.68 0.7199 0.6634 0.6708 238,422
Quote Details
52wk Low:0.601
52wk High:1.915
Vol:407.72K
Avg Vol(3m):9.1M
1Y Chng:-50.59%
1M Chng:-29.48%
Add to Watch List
More Information
Index US Composite
Market Cap. 37.87M